All terms in EFO
| Label | Id | Description |
|---|---|---|
| anomaly of puberty or/and menstrual cycle | MONDO_0015860 | |
| facial neuralgia | EFO_0009380 | [Neuralgic syndromes which feature chronic or recurrent facial pain as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions. [ MeSH:D005156 ], Neuralgic syndromes which feature chronic or recurrent facial pain as the primary manifestation of disease. Disorders of the trigeminal and facial nerves are frequently associated with these conditions.] |
| facial nerve disease | EFO_1002051 | [A disease involving the facial nerve.] |
| cranial neuralgia | MONDO_0016374 | [A neuralgia that involves the cranial neuron projection bundle.] |
| adactyly of foot | MONDO_0018563 | |
| non-syndromic terminal limb defects | MONDO_0017421 | |
| fibroblast growth factor 23 measurement | EFO_0009381 | [Quantification of the amount of fibroblast growth factor 23 in a sample] |
| phosphate ion homeostasis | GO_0055062 | [Any process involved in the maintenance of an internal steady state of phosphate ions within an organism or cell.] |
| genetic otorhinolaryngological malformation | MONDO_0018562 | |
| genetic head and neck malformation | MONDO_0015961 | |
| genetic otorhinolaryngologic disease | MONDO_0018751 | [An instance of otorhinolaryngologic disease that is caused by a modification of the individual's genome.] |
| phosphatidylcholine 36:1 measurement | EFO_0010379 | [The quantification of phosphatidylcholine 36:1 levels in a sample.] |
| phosphatidylcholine measurement | EFO_0010226 | [A quantification of phosphatidylcholines.] |
| Facial dysmorphism - macrocephaly - myopia - Dandy-Walker malformation | Orphanet_1970 | |
| Genetic syndrome with a Dandy-Walker malformation as major feature | Orphanet_269570 | |
| phosphatidylcholine 34:3 measurement | EFO_0010377 | [The quantification of phosphatidylcholine 34:3 levels in a sample.] |
| phosphatidylcholine 34:4 measurement | EFO_0010378 | [The quantification of phosphatidylcholine 34:4 levels in a sample.] |
| nervous system disease | EFO_0000618 | [a general class of medical conditions affecting the nervous system., A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.] |
| phosphatidylcholine 34:1 measurement | EFO_0010375 | [The quantification of phosphatidylcholine 34:1 levels in a sample.] |
| phosphatidylcholine 34:2 measurement | EFO_0010376 | [The quantification of phosphatidylcholine 34:2 levels in a sample.] |